Business Context and Reporting Period
This Form 8-K filing by iBio, Inc. (a Delaware corporation) reports on events occurring on November 30, 2017. The filing details the closing of a previously announced public offering of common stock.
Key Financial Metrics
- Offering Size: 22,500,000 shares of common stock.
- Public Offering Price: $0.20 per share.
- Gross Proceeds: Approximately $4.5 million (calculated from share count and price).
- Net Proceeds: Approximately $4.2 million after deducting underwriting discounts, commissions, and offering expenses.
- Underwriting Fees:
- 7% discount on shares purchased by "New Investors" (no pre-existing relationship).
- 3.5% discount on shares purchased by existing investors.
- Issuance of 110,000 shares (2% of shares sold to New Investors) to the Underwriter, Aegis Capital Corp.
- Over-Allotment Option: The Underwriter holds a 45-day option to purchase up to an additional 3,375,000 shares.
Material Changes
The primary material change is the increase in equity capital and cash liquidity resulting from the closing of the public offering. The filing does not provide comparative financial data (revenue, profit, or debt levels) for prior periods as this is a current report regarding a specific transaction rather than a periodic financial statement.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosures inherent in the underwriting agreement. The net proceeds figure assumes the Underwriter does not exercise the over-allotment option.
Investor Verification Checklist
- Verify the final number of shares sold if the 45-day over-allotment option is exercised.
- Confirm the exact breakdown of proceeds between "New Investors" and existing investors to understand the total fee impact.
- Review the "Amended and Restated Underwriting Agreement" (Exhibit 1.1) for specific covenants or restrictions.
- Check subsequent filings to determine how the $4.2 million in net proceeds is being utilized.